Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-03-16

Clinical Trial Update: Effects of Liraglutide in Chronic Obstructive Pulmonary Disease [Phase 4]

View source ↗

Summary

Clinical trial update for liraglutide in chronic obstructive pulmonary disease (Phase 4) completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • liraglutide (liraglutide)

Snippet

Sponsor: Claus Bogh Juhl | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 4 | Status: COMPLETED